Prometheus Biosciences Inc (RXDX) PT Raised to $55 at Stifel
Tweet
Share
E-mailGet Alerts RXDX Hot Sheet
Price: $199.92 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 24
Join SI Premium – FREE
Stifel analyst Annabel Samimy raised the price target on Prometheus Biosciences Inc (NASDAQ: RXDX) to $55.00 (from $50.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Bally's Corp (BALY) PT Lowered to $10; Truist Securities: 'Mixed results amidst a "going concern"'
- Keysight Technologies (KEYS) PT Raised to $440 at UBS Amid Broad-Based AI Strength
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
